Rational Antitussive Therapy in Children

Ye.A. Agafonova, Ye.A. Rusakova, V.I. Ivashina

Abstract


The article presents the current data about the state of the defense mechanisms of the respiratory tract in children. The questions of antitussive therapy in pediatrics are considered. Recommendations on the use of mucoregulatory agent Ambrolitin are giving.

Keywords


children; respiratory diseases; cough; mucolytic therapy.

References


Стартовая антибактериальная терапия внебольничных форм пневмонии у детей / А.Е. Абатуров, Е.А. Агафонова, О.М. Герасименко [и др.] // Современная педиатрия. — 2011. — № 4. — С. 95-98.

Цимбаліста О.Л. Порушення в системі зовнішнього дихання у дітей, хворих на ускладнену пневмонію / О.Л. Цимбаліста, О.І. Гаврилюк // Современная педиатрия. — 2011. — № 5/39. — С. 122-125.

Каракушикова А.С. Особенности иммунного статуса недоношенных детей с перинатальной патологией в раннем неонатальном периоде / А.С. Каракушикова, К.В. Рахимова, Г.М. Абдулаева // Педиатрия. — 2012. — Т. 91, № 1. — С. 20-25.

Современный макролид сумамед: трехлетний опыт клинического использования в терапии заболеваний нижних дыхательных путей у детей / Н.П. Гляделова, Н.К. Унич, В.А. Королева [и др.] // Современная педиатрия. — 2011. — № 1. — С. 35-38.

Baiardi P., Ceci A., Felisi M., Cantarutti L., Girotto S. et al. In-label and off-label use of respiratory drugs in the Italian paediatric populati­on // Acta Paediatr. — 2010. — 99. — 544-549.

Zuidgeest M.G., van Dijk L., Smit H.A., van der Wouden J.C., Brunekreef B. et al. Prescription of respiratory medication without an asthma diagnosis in children: a population based study // BMC Health Serv. Res. — 2008. — 8. — 16.

Bianchi M., Clavenna A., Sequi M., Bortolotti A., Fortino I. et al. Spirometry testing in a population of Italian children: age and gender differences // Respir. Med. — 2012. — 106. — 1383-1388.

Conroy S. Association between licence status and medication errors // Arch. Dis. Child. — 2011. — 96. — 305-306.

Neubert A., Dormann H., Weiss J., Egger T., Criegee-Rieck M. et al. The impact of unlicensed and off-label drug use on adverse drug reactions in paediatric patients // Drug Saf. — 2004. — 27. — 1059-1067.

Ufer M., Kimland E., Bergman U. Adverse drug reactions and off-label prescribing for paediatric outpatients: a one-year survey of spontaneous reports in Sweden // Pharmacoepidemiol Drug Saf. — 2004. — 13. — 147-152.

Bianchi M., Mantovani A., Erroi A., Dinarello A., Ghezzi Pl. Ambroxol inhibits interleukin 1 and tumor necrosis factor production in human mononuclear cells // Agent Actions. — 1990. — 31. — 275-9.

Nowak D., Antczak A., Krol M. Biolosiewicz, Pietras T. Antioxidant properties of ambroxol // Free Radiat. Biol. Med. — 1994. — 16. — 517-22.

Lee C.S., Jang Y.Y., Song J.S., Yoon Y.C., Hon E.S. Ambroxol inhibits peroxynitrite-induced damage of a α1-antiproteinase and free radical production in activated phygocytic cells // Pharmacol. Toxicol. — 2002. — 91. — 140-9.

Jang Y.Y., Song J.H., Shin Y.K., Hans E.S., Lee C.S. Depressant effects of ambroxol and erdosteine on cytokine synthesis, granule enzyme release, and free radical production in rat alveolar macrophages activated by lipopolysaccharide // Pharmacol Toxicol. — 2003. — 92. — 173-9.

Severina I.S., Bussygina O.G., Pyatakova N.V., Kinopor Y.V., Krosrioperor R.A. Ambroxol as an inhibitor of nitric oxide-dependent activation of soluble guanylate cyclase // Eur. J. Pharmacol. — 2000. — 407. — 61-4.

Gibbs B.F., Wolff H.H., Grabbe J. Ambroxol inhibitors IgE-dependent mediator secretion from human skin mast cells // Inflamm Res. — 2000. — 49. — S17-8.

Su X., Wang L., Song Y., Bai C. Inhibition of inflammatory responses by ambroxol: A mucolyte agent, in a murine model of acute lung injury induced by lipopolysaccharide // Intensive Care Med. — 2004. — 30. — 133-40.

Yang B., Yao D.F., Ohuchi M., Ide M., Yono M., Okumura Y. et al. Ambroxol suppresses influenza-virus proliferation in the mouse airway by increasing antiviral factor levels // Eur Respir J. — 2002. — 19. — 952-8.

Weiss T., Dorow P., Felix R. Mucociliary clearance under the secretolytic influence of ambroxol // Prax Pneumol. — 1981. — 35. — 359-62.

Tsunenari Y., Kast A., Honma M. Toxicity studies with ambroxol (Na 872) in rats, mice and rabbits // Pharmacometrics. — 1981. — 21. — 281-311.

Iida H., Kast A., Tsunenari Y. Teratology studies with ambroxol (NA-872) in rats and rabbits // Pharmacometrics. — 1981. — 21. — 271-9.




DOI: https://doi.org/10.22141/2224-0551.6.57.2014.75723

Refbacks

  • There are currently no refbacks.


Copyright (c) 2016 CHILD`S HEALTH

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.

 

© Publishing House Zaslavsky, 1997-2017

 

 Яндекс.МетрикаSeo анализ сайта Рейтинг@Mail.ru